nodes	percent_of_prediction	percent_of_DWPC	metapath
Temsirolimus—CYP3A7—Eplerenone—coronary artery disease	0.029	0.0451	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Eplerenone—coronary artery disease	0.029	0.0451	CbGbCtD
Temsirolimus—ABCB1—Ticagrelor—coronary artery disease	0.0246	0.0383	CbGbCtD
Temsirolimus—CYP3A5—Clopidogrel—coronary artery disease	0.0234	0.0364	CbGbCtD
Temsirolimus—CYP3A5—Eplerenone—coronary artery disease	0.0217	0.0338	CbGbCtD
Temsirolimus—CYP3A7—Simvastatin—coronary artery disease	0.0187	0.029	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Simvastatin—coronary artery disease	0.0187	0.029	CbGbCtD
Temsirolimus—CYP3A7—Lovastatin—coronary artery disease	0.0183	0.0284	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Lovastatin—coronary artery disease	0.0183	0.0284	CbGbCtD
Temsirolimus—CYP3A7—Atorvastatin—coronary artery disease	0.0167	0.0259	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Atorvastatin—coronary artery disease	0.0167	0.0259	CbGbCtD
Temsirolimus—ABCB1—Perindopril—coronary artery disease	0.0152	0.0237	CbGbCtD
Temsirolimus—ABCB1—Clopidogrel—coronary artery disease	0.0152	0.0237	CbGbCtD
Temsirolimus—CYP3A5—Rosuvastatin—coronary artery disease	0.0151	0.0234	CbGbCtD
Temsirolimus—CYP3A4—Ticagrelor—coronary artery disease	0.0148	0.0229	CbGbCtD
Temsirolimus—CYP3A5—Simvastatin—coronary artery disease	0.014	0.0218	CbGbCtD
Temsirolimus—CYP3A5—Pravastatin—coronary artery disease	0.0137	0.0213	CbGbCtD
Temsirolimus—CYP3A5—Lovastatin—coronary artery disease	0.0137	0.0213	CbGbCtD
Temsirolimus—ABCB1—Telmisartan—coronary artery disease	0.0133	0.0207	CbGbCtD
Temsirolimus—ABCB1—Pitavastatin—coronary artery disease	0.0133	0.0207	CbGbCtD
Temsirolimus—CYP3A4—Fenofibrate—coronary artery disease	0.0132	0.0205	CbGbCtD
Temsirolimus—ABCB1—Enalapril—coronary artery disease	0.0126	0.0196	CbGbCtD
Temsirolimus—ABCB1—Lisinopril—coronary artery disease	0.0126	0.0196	CbGbCtD
Temsirolimus—CYP3A5—Atorvastatin—coronary artery disease	0.0125	0.0194	CbGbCtD
Temsirolimus—CYP3A5—Losartan—coronary artery disease	0.0114	0.0178	CbGbCtD
Temsirolimus—CYP2D6—Niacin—coronary artery disease	0.0109	0.0169	CbGbCtD
Temsirolimus—ABCB1—Timolol—coronary artery disease	0.0107	0.0167	CbGbCtD
Temsirolimus—CYP3A4—Gemfibrozil—coronary artery disease	0.0105	0.0163	CbGbCtD
Temsirolimus—CYP2D6—Timolol—coronary artery disease	0.0101	0.0157	CbGbCtD
Temsirolimus—ABCB1—Ezetimibe—coronary artery disease	0.00981	0.0152	CbGbCtD
Temsirolimus—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00956	0.0149	CbGbCtD
Temsirolimus—ABCB1—Captopril—coronary artery disease	0.00944	0.0147	CbGbCtD
Temsirolimus—CYP3A4—Clopidogrel—coronary artery disease	0.00912	0.0142	CbGbCtD
Temsirolimus—ABCB1—Simvastatin—coronary artery disease	0.00912	0.0142	CbGbCtD
Temsirolimus—ABCB1—Pravastatin—coronary artery disease	0.00893	0.0139	CbGbCtD
Temsirolimus—ABCB1—Lovastatin—coronary artery disease	0.00893	0.0139	CbGbCtD
Temsirolimus—CYP2D6—Captopril—coronary artery disease	0.0089	0.0138	CbGbCtD
Temsirolimus—CYP2D6—Simvastatin—coronary artery disease	0.00859	0.0134	CbGbCtD
Temsirolimus—CYP3A4—Eplerenone—coronary artery disease	0.00848	0.0132	CbGbCtD
Temsirolimus—CYP2D6—Pravastatin—coronary artery disease	0.00841	0.0131	CbGbCtD
Temsirolimus—CYP2D6—Lovastatin—coronary artery disease	0.00841	0.0131	CbGbCtD
Temsirolimus—ABCB1—Atorvastatin—coronary artery disease	0.00813	0.0126	CbGbCtD
Temsirolimus—CYP2D6—Atorvastatin—coronary artery disease	0.00766	0.0119	CbGbCtD
Temsirolimus—CYP3A4—Enalapril—coronary artery disease	0.00756	0.0117	CbGbCtD
Temsirolimus—ABCB1—Losartan—coronary artery disease	0.00744	0.0116	CbGbCtD
Temsirolimus—CYP3A4—Rosuvastatin—coronary artery disease	0.00588	0.00913	CbGbCtD
Temsirolimus—CYP3A4—Ezetimibe—coronary artery disease	0.00588	0.00913	CbGbCtD
Temsirolimus—CYP3A4—Simvastatin—coronary artery disease	0.00547	0.00849	CbGbCtD
Temsirolimus—CYP3A4—Lovastatin—coronary artery disease	0.00535	0.00831	CbGbCtD
Temsirolimus—CYP3A4—Pravastatin—coronary artery disease	0.00535	0.00831	CbGbCtD
Temsirolimus—CYP3A4—Atorvastatin—coronary artery disease	0.00487	0.00757	CbGbCtD
Temsirolimus—CYP3A4—Losartan—coronary artery disease	0.00446	0.00692	CbGbCtD
Temsirolimus—Sirolimus—FGF2—coronary artery disease	0.00192	0.872	CrCbGaD
Temsirolimus—Tacrolimus—ALB—coronary artery disease	0.000282	0.128	CrCbGaD
Temsirolimus—Anxiety—Ramipril—coronary artery disease	6.91e-05	0.000304	CcSEcCtD
Temsirolimus—Vomiting—Lovastatin—coronary artery disease	6.9e-05	0.000304	CcSEcCtD
Temsirolimus—Somnolence—Losartan—coronary artery disease	6.9e-05	0.000304	CcSEcCtD
Temsirolimus—Dizziness—Eplerenone—coronary artery disease	6.89e-05	0.000303	CcSEcCtD
Temsirolimus—Rash—Clopidogrel—coronary artery disease	6.89e-05	0.000303	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	6.89e-05	0.000303	CcSEcCtD
Temsirolimus—Dermatitis—Clopidogrel—coronary artery disease	6.89e-05	0.000303	CcSEcCtD
Temsirolimus—Asthenia—Valsartan—coronary artery disease	6.88e-05	0.000303	CcSEcCtD
Temsirolimus—Hypertension—Timolol—coronary artery disease	6.88e-05	0.000303	CcSEcCtD
Temsirolimus—Pain—Furosemide—coronary artery disease	6.88e-05	0.000303	CcSEcCtD
Temsirolimus—Constipation—Furosemide—coronary artery disease	6.88e-05	0.000303	CcSEcCtD
Temsirolimus—Hypersensitivity—Niacin—coronary artery disease	6.87e-05	0.000302	CcSEcCtD
Temsirolimus—Asthenia—Olmesartan—coronary artery disease	6.85e-05	0.000301	CcSEcCtD
Temsirolimus—Headache—Clopidogrel—coronary artery disease	6.85e-05	0.000301	CcSEcCtD
Temsirolimus—Rash—Lovastatin—coronary artery disease	6.85e-05	0.000301	CcSEcCtD
Temsirolimus—Dermatitis—Lovastatin—coronary artery disease	6.84e-05	0.000301	CcSEcCtD
Temsirolimus—Anaemia—Lisinopril—coronary artery disease	6.83e-05	0.000301	CcSEcCtD
Temsirolimus—Headache—Lovastatin—coronary artery disease	6.8e-05	0.000299	CcSEcCtD
Temsirolimus—Pruritus—Valsartan—coronary artery disease	6.79e-05	0.000299	CcSEcCtD
Temsirolimus—Arthralgia—Timolol—coronary artery disease	6.78e-05	0.000299	CcSEcCtD
Temsirolimus—Chest pain—Timolol—coronary artery disease	6.78e-05	0.000299	CcSEcCtD
Temsirolimus—Myalgia—Timolol—coronary artery disease	6.78e-05	0.000299	CcSEcCtD
Temsirolimus—Vomiting—Ezetimibe—coronary artery disease	6.77e-05	0.000298	CcSEcCtD
Temsirolimus—Hypersensitivity—Pravastatin—coronary artery disease	6.77e-05	0.000298	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Perindopril—coronary artery disease	6.76e-05	0.000298	CcSEcCtD
Temsirolimus—Anxiety—Timolol—coronary artery disease	6.76e-05	0.000298	CcSEcCtD
Temsirolimus—Angioedema—Lisinopril—coronary artery disease	6.75e-05	0.000297	CcSEcCtD
Temsirolimus—Pruritus—Olmesartan—coronary artery disease	6.75e-05	0.000297	CcSEcCtD
Temsirolimus—Decreased appetite—Losartan—coronary artery disease	6.74e-05	0.000297	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	6.74e-05	0.000296	CcSEcCtD
Temsirolimus—Abdominal pain—Captopril—coronary artery disease	6.73e-05	0.000296	CcSEcCtD
Temsirolimus—Body temperature increased—Captopril—coronary artery disease	6.73e-05	0.000296	CcSEcCtD
Temsirolimus—Dizziness—Simvastatin—coronary artery disease	6.72e-05	0.000296	CcSEcCtD
Temsirolimus—Rash—Ezetimibe—coronary artery disease	6.72e-05	0.000296	CcSEcCtD
Temsirolimus—Dermatitis—Ezetimibe—coronary artery disease	6.71e-05	0.000295	CcSEcCtD
Temsirolimus—Asthenia—Niacin—coronary artery disease	6.69e-05	0.000294	CcSEcCtD
Temsirolimus—Fatigue—Losartan—coronary artery disease	6.69e-05	0.000294	CcSEcCtD
Temsirolimus—Headache—Ezetimibe—coronary artery disease	6.67e-05	0.000294	CcSEcCtD
Temsirolimus—Anaphylactic shock—Ramipril—coronary artery disease	6.65e-05	0.000293	CcSEcCtD
Temsirolimus—Oedema—Ramipril—coronary artery disease	6.65e-05	0.000293	CcSEcCtD
Temsirolimus—Pain—Losartan—coronary artery disease	6.63e-05	0.000292	CcSEcCtD
Temsirolimus—Constipation—Losartan—coronary artery disease	6.63e-05	0.000292	CcSEcCtD
Temsirolimus—Vomiting—Eplerenone—coronary artery disease	6.63e-05	0.000292	CcSEcCtD
Temsirolimus—Leukopenia—Lisinopril—coronary artery disease	6.62e-05	0.000291	CcSEcCtD
Temsirolimus—Nausea—Fenofibrate—coronary artery disease	6.61e-05	0.000291	CcSEcCtD
Temsirolimus—Pruritus—Niacin—coronary artery disease	6.6e-05	0.00029	CcSEcCtD
Temsirolimus—Asthenia—Pravastatin—coronary artery disease	6.59e-05	0.00029	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Furosemide—coronary artery disease	6.57e-05	0.000289	CcSEcCtD
Temsirolimus—Rash—Eplerenone—coronary artery disease	6.57e-05	0.000289	CcSEcCtD
Temsirolimus—Hypersensitivity—Trandolapril—coronary artery disease	6.57e-05	0.000289	CcSEcCtD
Temsirolimus—Dermatitis—Eplerenone—coronary artery disease	6.57e-05	0.000289	CcSEcCtD
Temsirolimus—Diarrhoea—Valsartan—coronary artery disease	6.56e-05	0.000289	CcSEcCtD
Temsirolimus—Hypersensitivity—Enalapril—coronary artery disease	6.54e-05	0.000288	CcSEcCtD
Temsirolimus—Body temperature increased—Perindopril—coronary artery disease	6.54e-05	0.000288	CcSEcCtD
Temsirolimus—Abdominal pain—Perindopril—coronary artery disease	6.54e-05	0.000288	CcSEcCtD
Temsirolimus—Diarrhoea—Olmesartan—coronary artery disease	6.53e-05	0.000287	CcSEcCtD
Temsirolimus—Headache—Eplerenone—coronary artery disease	6.53e-05	0.000287	CcSEcCtD
Temsirolimus—Nervous system disorder—Ramipril—coronary artery disease	6.52e-05	0.000287	CcSEcCtD
Temsirolimus—Thrombocytopenia—Ramipril—coronary artery disease	6.51e-05	0.000287	CcSEcCtD
Temsirolimus—Anaphylactic shock—Timolol—coronary artery disease	6.5e-05	0.000286	CcSEcCtD
Temsirolimus—Oedema—Timolol—coronary artery disease	6.5e-05	0.000286	CcSEcCtD
Temsirolimus—Pruritus—Pravastatin—coronary artery disease	6.5e-05	0.000286	CcSEcCtD
Temsirolimus—Nausea—Clopidogrel—coronary artery disease	6.49e-05	0.000286	CcSEcCtD
Temsirolimus—Skin disorder—Ramipril—coronary artery disease	6.46e-05	0.000284	CcSEcCtD
Temsirolimus—Infection—Timolol—coronary artery disease	6.46e-05	0.000284	CcSEcCtD
Temsirolimus—Vomiting—Simvastatin—coronary artery disease	6.46e-05	0.000284	CcSEcCtD
Temsirolimus—Hypersensitivity—Telmisartan—coronary artery disease	6.45e-05	0.000284	CcSEcCtD
Temsirolimus—Cough—Lisinopril—coronary artery disease	6.45e-05	0.000284	CcSEcCtD
Temsirolimus—Nausea—Lovastatin—coronary artery disease	6.45e-05	0.000284	CcSEcCtD
Temsirolimus—Rash—Simvastatin—coronary artery disease	6.4e-05	0.000282	CcSEcCtD
Temsirolimus—Dermatitis—Simvastatin—coronary artery disease	6.4e-05	0.000282	CcSEcCtD
Temsirolimus—Asthenia—Trandolapril—coronary artery disease	6.4e-05	0.000282	CcSEcCtD
Temsirolimus—Diarrhoea—Niacin—coronary artery disease	6.38e-05	0.000281	CcSEcCtD
Temsirolimus—Nervous system disorder—Timolol—coronary artery disease	6.38e-05	0.000281	CcSEcCtD
Temsirolimus—Asthenia—Enalapril—coronary artery disease	6.37e-05	0.00028	CcSEcCtD
Temsirolimus—Headache—Simvastatin—coronary artery disease	6.36e-05	0.00028	CcSEcCtD
Temsirolimus—Body temperature increased—Furosemide—coronary artery disease	6.36e-05	0.00028	CcSEcCtD
Temsirolimus—Abdominal pain—Furosemide—coronary artery disease	6.36e-05	0.00028	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Losartan—coronary artery disease	6.34e-05	0.000279	CcSEcCtD
Temsirolimus—Dizziness—Valsartan—coronary artery disease	6.34e-05	0.000279	CcSEcCtD
Temsirolimus—Anorexia—Ramipril—coronary artery disease	6.34e-05	0.000279	CcSEcCtD
Temsirolimus—Nausea—Ezetimibe—coronary artery disease	6.33e-05	0.000278	CcSEcCtD
Temsirolimus—Skin disorder—Timolol—coronary artery disease	6.32e-05	0.000278	CcSEcCtD
Temsirolimus—Dizziness—Olmesartan—coronary artery disease	6.31e-05	0.000278	CcSEcCtD
Temsirolimus—Pruritus—Trandolapril—coronary artery disease	6.31e-05	0.000278	CcSEcCtD
Temsirolimus—Myalgia—Lisinopril—coronary artery disease	6.29e-05	0.000277	CcSEcCtD
Temsirolimus—Arthralgia—Lisinopril—coronary artery disease	6.29e-05	0.000277	CcSEcCtD
Temsirolimus—Chest pain—Lisinopril—coronary artery disease	6.29e-05	0.000277	CcSEcCtD
Temsirolimus—Asthenia—Telmisartan—coronary artery disease	6.28e-05	0.000277	CcSEcCtD
Temsirolimus—Pruritus—Enalapril—coronary artery disease	6.28e-05	0.000277	CcSEcCtD
Temsirolimus—Diarrhoea—Pravastatin—coronary artery disease	6.28e-05	0.000277	CcSEcCtD
Temsirolimus—Anxiety—Lisinopril—coronary artery disease	6.27e-05	0.000276	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	6.25e-05	0.000275	CcSEcCtD
Temsirolimus—Anorexia—Timolol—coronary artery disease	6.2e-05	0.000273	CcSEcCtD
Temsirolimus—Pruritus—Telmisartan—coronary artery disease	6.2e-05	0.000273	CcSEcCtD
Temsirolimus—Nausea—Eplerenone—coronary artery disease	6.19e-05	0.000273	CcSEcCtD
Temsirolimus—Dizziness—Niacin—coronary artery disease	6.17e-05	0.000271	CcSEcCtD
Temsirolimus—Abdominal pain—Losartan—coronary artery disease	6.13e-05	0.00027	CcSEcCtD
Temsirolimus—Body temperature increased—Losartan—coronary artery disease	6.13e-05	0.00027	CcSEcCtD
Temsirolimus—Asthenia—Captopril—coronary artery disease	6.11e-05	0.000269	CcSEcCtD
Temsirolimus—Diarrhoea—Trandolapril—coronary artery disease	6.1e-05	0.000269	CcSEcCtD
Temsirolimus—Vomiting—Valsartan—coronary artery disease	6.1e-05	0.000268	CcSEcCtD
Temsirolimus—Diarrhoea—Enalapril—coronary artery disease	6.08e-05	0.000267	CcSEcCtD
Temsirolimus—Dizziness—Pravastatin—coronary artery disease	6.07e-05	0.000267	CcSEcCtD
Temsirolimus—Vomiting—Olmesartan—coronary artery disease	6.07e-05	0.000267	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Ramipril—coronary artery disease	6.06e-05	0.000267	CcSEcCtD
Temsirolimus—Rash—Valsartan—coronary artery disease	6.05e-05	0.000266	CcSEcCtD
Temsirolimus—Dermatitis—Valsartan—coronary artery disease	6.04e-05	0.000266	CcSEcCtD
Temsirolimus—Nausea—Simvastatin—coronary artery disease	6.03e-05	0.000266	CcSEcCtD
Temsirolimus—Anaphylactic shock—Lisinopril—coronary artery disease	6.03e-05	0.000266	CcSEcCtD
Temsirolimus—Oedema—Lisinopril—coronary artery disease	6.03e-05	0.000266	CcSEcCtD
Temsirolimus—Pruritus—Captopril—coronary artery disease	6.03e-05	0.000265	CcSEcCtD
Temsirolimus—Rash—Olmesartan—coronary artery disease	6.02e-05	0.000265	CcSEcCtD
Temsirolimus—Insomnia—Ramipril—coronary artery disease	6.02e-05	0.000265	CcSEcCtD
Temsirolimus—Dermatitis—Olmesartan—coronary artery disease	6.01e-05	0.000265	CcSEcCtD
Temsirolimus—Headache—Valsartan—coronary artery disease	6.01e-05	0.000264	CcSEcCtD
Temsirolimus—Diarrhoea—Telmisartan—coronary artery disease	5.99e-05	0.000264	CcSEcCtD
Temsirolimus—Infection—Lisinopril—coronary artery disease	5.99e-05	0.000264	CcSEcCtD
Temsirolimus—Headache—Olmesartan—coronary artery disease	5.98e-05	0.000263	CcSEcCtD
Temsirolimus—Asthenia—Perindopril—coronary artery disease	5.93e-05	0.000261	CcSEcCtD
Temsirolimus—Dyspnoea—Ramipril—coronary artery disease	5.93e-05	0.000261	CcSEcCtD
Temsirolimus—Vomiting—Niacin—coronary artery disease	5.93e-05	0.000261	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Timolol—coronary artery disease	5.92e-05	0.000261	CcSEcCtD
Temsirolimus—Hypersensitivity—Furosemide—coronary artery disease	5.92e-05	0.000261	CcSEcCtD
Temsirolimus—Somnolence—Ramipril—coronary artery disease	5.91e-05	0.00026	CcSEcCtD
Temsirolimus—Thrombocytopenia—Lisinopril—coronary artery disease	5.91e-05	0.00026	CcSEcCtD
Temsirolimus—Dizziness—Trandolapril—coronary artery disease	5.9e-05	0.00026	CcSEcCtD
Temsirolimus—Insomnia—Timolol—coronary artery disease	5.88e-05	0.000259	CcSEcCtD
Temsirolimus—Rash—Niacin—coronary artery disease	5.88e-05	0.000259	CcSEcCtD
Temsirolimus—Dermatitis—Niacin—coronary artery disease	5.87e-05	0.000259	CcSEcCtD
Temsirolimus—Dizziness—Enalapril—coronary artery disease	5.87e-05	0.000258	CcSEcCtD
Temsirolimus—Skin disorder—Lisinopril—coronary artery disease	5.86e-05	0.000258	CcSEcCtD
Temsirolimus—Pruritus—Perindopril—coronary artery disease	5.85e-05	0.000258	CcSEcCtD
Temsirolimus—Headache—Niacin—coronary artery disease	5.84e-05	0.000257	CcSEcCtD
Temsirolimus—Vomiting—Pravastatin—coronary artery disease	5.84e-05	0.000257	CcSEcCtD
Temsirolimus—Diarrhoea—Captopril—coronary artery disease	5.83e-05	0.000257	CcSEcCtD
Temsirolimus—Dyspnoea—Timolol—coronary artery disease	5.8e-05	0.000255	CcSEcCtD
Temsirolimus—Dizziness—Telmisartan—coronary artery disease	5.79e-05	0.000255	CcSEcCtD
Temsirolimus—Rash—Pravastatin—coronary artery disease	5.79e-05	0.000255	CcSEcCtD
Temsirolimus—Dermatitis—Pravastatin—coronary artery disease	5.78e-05	0.000255	CcSEcCtD
Temsirolimus—Decreased appetite—Ramipril—coronary artery disease	5.78e-05	0.000254	CcSEcCtD
Temsirolimus—Somnolence—Timolol—coronary artery disease	5.78e-05	0.000254	CcSEcCtD
Temsirolimus—Asthenia—Furosemide—coronary artery disease	5.77e-05	0.000254	CcSEcCtD
Temsirolimus—Headache—Pravastatin—coronary artery disease	5.75e-05	0.000253	CcSEcCtD
Temsirolimus—Anorexia—Lisinopril—coronary artery disease	5.75e-05	0.000253	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Ramipril—coronary artery disease	5.74e-05	0.000253	CcSEcCtD
Temsirolimus—Fatigue—Ramipril—coronary artery disease	5.73e-05	0.000252	CcSEcCtD
Temsirolimus—Hypersensitivity—Losartan—coronary artery disease	5.72e-05	0.000252	CcSEcCtD
Temsirolimus—Nausea—Valsartan—coronary artery disease	5.7e-05	0.000251	CcSEcCtD
Temsirolimus—Pruritus—Furosemide—coronary artery disease	5.69e-05	0.00025	CcSEcCtD
Temsirolimus—Constipation—Ramipril—coronary artery disease	5.69e-05	0.00025	CcSEcCtD
Temsirolimus—Nausea—Olmesartan—coronary artery disease	5.67e-05	0.00025	CcSEcCtD
Temsirolimus—Vomiting—Trandolapril—coronary artery disease	5.67e-05	0.00025	CcSEcCtD
Temsirolimus—Diarrhoea—Perindopril—coronary artery disease	5.66e-05	0.000249	CcSEcCtD
Temsirolimus—Decreased appetite—Timolol—coronary artery disease	5.65e-05	0.000249	CcSEcCtD
Temsirolimus—Vomiting—Enalapril—coronary artery disease	5.65e-05	0.000249	CcSEcCtD
Temsirolimus—Dizziness—Captopril—coronary artery disease	5.63e-05	0.000248	CcSEcCtD
Temsirolimus—Rash—Trandolapril—coronary artery disease	5.62e-05	0.000247	CcSEcCtD
Temsirolimus—Dermatitis—Trandolapril—coronary artery disease	5.62e-05	0.000247	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Timolol—coronary artery disease	5.61e-05	0.000247	CcSEcCtD
Temsirolimus—Fatigue—Timolol—coronary artery disease	5.61e-05	0.000247	CcSEcCtD
Temsirolimus—Rash—Enalapril—coronary artery disease	5.6e-05	0.000246	CcSEcCtD
Temsirolimus—Dermatitis—Enalapril—coronary artery disease	5.59e-05	0.000246	CcSEcCtD
Temsirolimus—Headache—Trandolapril—coronary artery disease	5.59e-05	0.000246	CcSEcCtD
Temsirolimus—Vomiting—Telmisartan—coronary artery disease	5.57e-05	0.000245	CcSEcCtD
Temsirolimus—Asthenia—Losartan—coronary artery disease	5.57e-05	0.000245	CcSEcCtD
Temsirolimus—Headache—Enalapril—coronary artery disease	5.56e-05	0.000245	CcSEcCtD
Temsirolimus—Pain—Timolol—coronary artery disease	5.56e-05	0.000245	CcSEcCtD
Temsirolimus—Nausea—Niacin—coronary artery disease	5.54e-05	0.000244	CcSEcCtD
Temsirolimus—Rash—Telmisartan—coronary artery disease	5.52e-05	0.000243	CcSEcCtD
Temsirolimus—Dermatitis—Telmisartan—coronary artery disease	5.52e-05	0.000243	CcSEcCtD
Temsirolimus—Diarrhoea—Furosemide—coronary artery disease	5.5e-05	0.000242	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Lisinopril—coronary artery disease	5.5e-05	0.000242	CcSEcCtD
Temsirolimus—Pruritus—Losartan—coronary artery disease	5.49e-05	0.000242	CcSEcCtD
Temsirolimus—Headache—Telmisartan—coronary artery disease	5.49e-05	0.000242	CcSEcCtD
Temsirolimus—Dizziness—Perindopril—coronary artery disease	5.47e-05	0.000241	CcSEcCtD
Temsirolimus—Insomnia—Lisinopril—coronary artery disease	5.46e-05	0.00024	CcSEcCtD
Temsirolimus—Nausea—Pravastatin—coronary artery disease	5.45e-05	0.00024	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Ramipril—coronary artery disease	5.44e-05	0.000239	CcSEcCtD
Temsirolimus—Vomiting—Captopril—coronary artery disease	5.42e-05	0.000238	CcSEcCtD
Temsirolimus—Dyspnoea—Lisinopril—coronary artery disease	5.38e-05	0.000237	CcSEcCtD
Temsirolimus—Rash—Captopril—coronary artery disease	5.37e-05	0.000236	CcSEcCtD
Temsirolimus—Dermatitis—Captopril—coronary artery disease	5.37e-05	0.000236	CcSEcCtD
Temsirolimus—Somnolence—Lisinopril—coronary artery disease	5.36e-05	0.000236	CcSEcCtD
Temsirolimus—Headache—Captopril—coronary artery disease	5.34e-05	0.000235	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Timolol—coronary artery disease	5.32e-05	0.000234	CcSEcCtD
Temsirolimus—Dizziness—Furosemide—coronary artery disease	5.32e-05	0.000234	CcSEcCtD
Temsirolimus—Diarrhoea—Losartan—coronary artery disease	5.31e-05	0.000234	CcSEcCtD
Temsirolimus—Nausea—Trandolapril—coronary artery disease	5.3e-05	0.000233	CcSEcCtD
Temsirolimus—Nausea—Enalapril—coronary artery disease	5.28e-05	0.000232	CcSEcCtD
Temsirolimus—Vomiting—Perindopril—coronary artery disease	5.26e-05	0.000231	CcSEcCtD
Temsirolimus—Body temperature increased—Ramipril—coronary artery disease	5.26e-05	0.000231	CcSEcCtD
Temsirolimus—Abdominal pain—Ramipril—coronary artery disease	5.26e-05	0.000231	CcSEcCtD
Temsirolimus—Decreased appetite—Lisinopril—coronary artery disease	5.24e-05	0.000231	CcSEcCtD
Temsirolimus—Rash—Perindopril—coronary artery disease	5.21e-05	0.00023	CcSEcCtD
Temsirolimus—Dermatitis—Perindopril—coronary artery disease	5.21e-05	0.000229	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Lisinopril—coronary artery disease	5.21e-05	0.000229	CcSEcCtD
Temsirolimus—Nausea—Telmisartan—coronary artery disease	5.2e-05	0.000229	CcSEcCtD
Temsirolimus—Fatigue—Lisinopril—coronary artery disease	5.2e-05	0.000229	CcSEcCtD
Temsirolimus—Headache—Perindopril—coronary artery disease	5.18e-05	0.000228	CcSEcCtD
Temsirolimus—Pain—Lisinopril—coronary artery disease	5.16e-05	0.000227	CcSEcCtD
Temsirolimus—Constipation—Lisinopril—coronary artery disease	5.16e-05	0.000227	CcSEcCtD
Temsirolimus—Abdominal pain—Timolol—coronary artery disease	5.14e-05	0.000226	CcSEcCtD
Temsirolimus—Body temperature increased—Timolol—coronary artery disease	5.14e-05	0.000226	CcSEcCtD
Temsirolimus—Dizziness—Losartan—coronary artery disease	5.13e-05	0.000226	CcSEcCtD
Temsirolimus—Vomiting—Furosemide—coronary artery disease	5.11e-05	0.000225	CcSEcCtD
Temsirolimus—Rash—Furosemide—coronary artery disease	5.07e-05	0.000223	CcSEcCtD
Temsirolimus—Dermatitis—Furosemide—coronary artery disease	5.06e-05	0.000223	CcSEcCtD
Temsirolimus—Nausea—Captopril—coronary artery disease	5.06e-05	0.000223	CcSEcCtD
Temsirolimus—Headache—Furosemide—coronary artery disease	5.04e-05	0.000222	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Lisinopril—coronary artery disease	4.93e-05	0.000217	CcSEcCtD
Temsirolimus—Vomiting—Losartan—coronary artery disease	4.93e-05	0.000217	CcSEcCtD
Temsirolimus—Nausea—Perindopril—coronary artery disease	4.91e-05	0.000216	CcSEcCtD
Temsirolimus—Hypersensitivity—Ramipril—coronary artery disease	4.9e-05	0.000216	CcSEcCtD
Temsirolimus—Rash—Losartan—coronary artery disease	4.89e-05	0.000215	CcSEcCtD
Temsirolimus—Dermatitis—Losartan—coronary artery disease	4.89e-05	0.000215	CcSEcCtD
Temsirolimus—Headache—Losartan—coronary artery disease	4.86e-05	0.000214	CcSEcCtD
Temsirolimus—Hypersensitivity—Timolol—coronary artery disease	4.79e-05	0.000211	CcSEcCtD
Temsirolimus—Nausea—Furosemide—coronary artery disease	4.78e-05	0.00021	CcSEcCtD
Temsirolimus—Asthenia—Ramipril—coronary artery disease	4.77e-05	0.00021	CcSEcCtD
Temsirolimus—Body temperature increased—Lisinopril—coronary artery disease	4.77e-05	0.00021	CcSEcCtD
Temsirolimus—Abdominal pain—Lisinopril—coronary artery disease	4.77e-05	0.00021	CcSEcCtD
Temsirolimus—Pruritus—Ramipril—coronary artery disease	4.71e-05	0.000207	CcSEcCtD
Temsirolimus—Asthenia—Timolol—coronary artery disease	4.67e-05	0.000205	CcSEcCtD
Temsirolimus—Nausea—Losartan—coronary artery disease	4.61e-05	0.000203	CcSEcCtD
Temsirolimus—Pruritus—Timolol—coronary artery disease	4.6e-05	0.000202	CcSEcCtD
Temsirolimus—Diarrhoea—Ramipril—coronary artery disease	4.55e-05	0.0002	CcSEcCtD
Temsirolimus—Diarrhoea—Timolol—coronary artery disease	4.45e-05	0.000196	CcSEcCtD
Temsirolimus—Hypersensitivity—Lisinopril—coronary artery disease	4.44e-05	0.000196	CcSEcCtD
Temsirolimus—Dizziness—Ramipril—coronary artery disease	4.4e-05	0.000194	CcSEcCtD
Temsirolimus—Asthenia—Lisinopril—coronary artery disease	4.33e-05	0.00019	CcSEcCtD
Temsirolimus—Dizziness—Timolol—coronary artery disease	4.3e-05	0.000189	CcSEcCtD
Temsirolimus—Pruritus—Lisinopril—coronary artery disease	4.27e-05	0.000188	CcSEcCtD
Temsirolimus—Vomiting—Ramipril—coronary artery disease	4.23e-05	0.000186	CcSEcCtD
Temsirolimus—Rash—Ramipril—coronary artery disease	4.19e-05	0.000185	CcSEcCtD
Temsirolimus—Dermatitis—Ramipril—coronary artery disease	4.19e-05	0.000184	CcSEcCtD
Temsirolimus—Headache—Ramipril—coronary artery disease	4.17e-05	0.000183	CcSEcCtD
Temsirolimus—Vomiting—Timolol—coronary artery disease	4.13e-05	0.000182	CcSEcCtD
Temsirolimus—Diarrhoea—Lisinopril—coronary artery disease	4.13e-05	0.000182	CcSEcCtD
Temsirolimus—Rash—Timolol—coronary artery disease	4.1e-05	0.00018	CcSEcCtD
Temsirolimus—Dermatitis—Timolol—coronary artery disease	4.1e-05	0.00018	CcSEcCtD
Temsirolimus—Headache—Timolol—coronary artery disease	4.07e-05	0.000179	CcSEcCtD
Temsirolimus—Dizziness—Lisinopril—coronary artery disease	3.99e-05	0.000176	CcSEcCtD
Temsirolimus—Nausea—Ramipril—coronary artery disease	3.95e-05	0.000174	CcSEcCtD
Temsirolimus—Nausea—Timolol—coronary artery disease	3.86e-05	0.00017	CcSEcCtD
Temsirolimus—Vomiting—Lisinopril—coronary artery disease	3.84e-05	0.000169	CcSEcCtD
Temsirolimus—Rash—Lisinopril—coronary artery disease	3.8e-05	0.000167	CcSEcCtD
Temsirolimus—Dermatitis—Lisinopril—coronary artery disease	3.8e-05	0.000167	CcSEcCtD
Temsirolimus—Headache—Lisinopril—coronary artery disease	3.78e-05	0.000166	CcSEcCtD
Temsirolimus—Nausea—Lisinopril—coronary artery disease	3.58e-05	0.000158	CcSEcCtD
Temsirolimus—CYP3A5—Metabolism—ABCA1—coronary artery disease	5.68e-06	4.47e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ALDH2—coronary artery disease	5.65e-06	4.45e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ALDOA—coronary artery disease	5.64e-06	4.44e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—HK2—coronary artery disease	5.64e-06	4.44e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—AKR1B1—coronary artery disease	5.64e-06	4.44e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—HIF1A—coronary artery disease	5.61e-06	4.41e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—AGT—coronary artery disease	5.59e-06	4.4e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—MTHFR—coronary artery disease	5.55e-06	4.37e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—HBA1—coronary artery disease	5.51e-06	4.34e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—LIPC—coronary artery disease	5.51e-06	4.34e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CYP2C19—coronary artery disease	5.51e-06	4.34e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PIK3C2A—coronary artery disease	5.51e-06	4.34e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GGT1—coronary artery disease	5.5e-06	4.33e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GOT1—coronary artery disease	5.5e-06	4.33e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—DCN—coronary artery disease	5.48e-06	4.31e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—APOC3—coronary artery disease	5.48e-06	4.31e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—LEP—coronary artery disease	5.47e-06	4.31e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—APOE—coronary artery disease	5.47e-06	4.31e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—LDLR—coronary artery disease	5.44e-06	4.28e-05	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—IL6—coronary artery disease	5.43e-06	4.27e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—APOA1—coronary artery disease	5.41e-06	4.26e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—SLC27A1—coronary artery disease	5.41e-06	4.26e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL1B—coronary artery disease	5.4e-06	4.25e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—SLC9A1—coronary artery disease	5.38e-06	4.23e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GSTT1—coronary artery disease	5.38e-06	4.23e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—KDR—coronary artery disease	5.36e-06	4.22e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—PTGS2—coronary artery disease	5.36e-06	4.22e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ALDH2—coronary artery disease	5.33e-06	4.19e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MAPK14—coronary artery disease	5.33e-06	4.19e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CETP—coronary artery disease	5.32e-06	4.18e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GCLC—coronary artery disease	5.32e-06	4.18e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—LCAT—coronary artery disease	5.3e-06	4.17e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CPT1B—coronary artery disease	5.3e-06	4.17e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—AGT—coronary artery disease	5.27e-06	4.15e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—SDC1—coronary artery disease	5.26e-06	4.14e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—VEGFA—coronary artery disease	5.25e-06	4.14e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—ESR1—coronary artery disease	5.23e-06	4.11e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	5.22e-06	4.11e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—APOA4—coronary artery disease	5.2e-06	4.1e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—HBA1—coronary artery disease	5.19e-06	4.09e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PIK3C2A—coronary artery disease	5.19e-06	4.09e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—LIPC—coronary artery disease	5.19e-06	4.09e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CYP2C19—coronary artery disease	5.19e-06	4.09e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—IL6—coronary artery disease	5.19e-06	4.08e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—APOE—coronary artery disease	5.17e-06	4.07e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—F2—coronary artery disease	5.16e-06	4.06e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—FN1—coronary artery disease	5.16e-06	4.06e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—APOC3—coronary artery disease	5.16e-06	4.06e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL6ST—coronary artery disease	5.14e-06	4.05e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—LDLR—coronary artery disease	5.13e-06	4.04e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—APOA1—coronary artery disease	5.11e-06	4.02e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NFKBIA—coronary artery disease	5.1e-06	4.02e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GSTT1—coronary artery disease	5.07e-06	3.99e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—SLC9A1—coronary artery disease	5.07e-06	3.99e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GCLM—coronary artery disease	5.02e-06	3.96e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PDHA1—coronary artery disease	5.02e-06	3.96e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GCLC—coronary artery disease	5.01e-06	3.94e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CETP—coronary artery disease	5.01e-06	3.94e-05	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—AKT1—coronary artery disease	5.01e-06	3.94e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PSMA6—coronary artery disease	4.97e-06	3.91e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PSMB5—coronary artery disease	4.97e-06	3.91e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—SDC1—coronary artery disease	4.95e-06	3.9e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—KIT—coronary artery disease	4.94e-06	3.89e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GSTP1—coronary artery disease	4.94e-06	3.89e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PPARGC1A—coronary artery disease	4.89e-06	3.85e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—HMOX1—coronary artery disease	4.87e-06	3.84e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CYP11B2—coronary artery disease	4.87e-06	3.83e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—TXNRD1—coronary artery disease	4.87e-06	3.83e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CTGF—coronary artery disease	4.85e-06	3.82e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TGFB1—coronary artery disease	4.82e-06	3.8e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GOT2—coronary artery disease	4.81e-06	3.78e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—HMGCR—coronary artery disease	4.81e-06	3.78e-05	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—AKT1—coronary artery disease	4.81e-06	3.78e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CAT—coronary artery disease	4.81e-06	3.78e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—SLC22A3—coronary artery disease	4.79e-06	3.77e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—AKT1—coronary artery disease	4.79e-06	3.77e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—GSK3B—coronary artery disease	4.74e-06	3.73e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MAPK1—coronary artery disease	4.73e-06	3.72e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—HADH—coronary artery disease	4.72e-06	3.72e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ARNTL—coronary artery disease	4.72e-06	3.72e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	4.71e-06	3.71e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—POMC—coronary artery disease	4.7e-06	3.7e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CREB1—coronary artery disease	4.7e-06	3.7e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PSMA6—coronary artery disease	4.68e-06	3.68e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PSMB5—coronary artery disease	4.68e-06	3.68e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—APOB—coronary artery disease	4.67e-06	3.67e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCL2—coronary artery disease	4.6e-06	3.62e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL6R—coronary artery disease	4.59e-06	3.61e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CTGF—coronary artery disease	4.57e-06	3.6e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GSTM1—coronary artery disease	4.54e-06	3.57e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—HMGCR—coronary artery disease	4.53e-06	3.57e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GOT2—coronary artery disease	4.53e-06	3.57e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IGF1—coronary artery disease	4.52e-06	3.56e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PPARG—coronary artery disease	4.5e-06	3.54e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	4.48e-06	3.53e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—APOA2—coronary artery disease	4.48e-06	3.53e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GPX2—coronary artery disease	4.48e-06	3.53e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—LPL—coronary artery disease	4.46e-06	3.51e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—POMC—coronary artery disease	4.44e-06	3.49e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—HK1—coronary artery disease	4.42e-06	3.48e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—SULT1A1—coronary artery disease	4.42e-06	3.48e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ABCG5—coronary artery disease	4.42e-06	3.48e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GPX4—coronary artery disease	4.42e-06	3.48e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PLCB1—coronary artery disease	4.42e-06	3.48e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—HADHA—coronary artery disease	4.37e-06	3.44e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GPX1—coronary artery disease	4.35e-06	3.42e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GSTA1—coronary artery disease	4.32e-06	3.4e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—SERPINE1—coronary artery disease	4.29e-06	3.38e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ABCA1—coronary artery disease	4.28e-06	3.37e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—LPA—coronary artery disease	4.27e-06	3.36e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CD36—coronary artery disease	4.23e-06	3.33e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PPP2CA—coronary artery disease	4.18e-06	3.29e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PLCB1—coronary artery disease	4.17e-06	3.28e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—FGF2—coronary artery disease	4.16e-06	3.27e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GGT1—coronary artery disease	4.15e-06	3.27e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GOT1—coronary artery disease	4.15e-06	3.27e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PLCB3—coronary artery disease	4.14e-06	3.26e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—MAPK1—coronary artery disease	4.11e-06	3.24e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—PIK3CA—coronary artery disease	4.1e-06	3.23e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NOS3—coronary artery disease	4.1e-06	3.23e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—APOA5—coronary artery disease	4.1e-06	3.23e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—ALB—coronary artery disease	4.05e-06	3.19e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ABCA1—coronary artery disease	4.04e-06	3.18e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—P4HB—coronary artery disease	4.02e-06	3.16e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—MTHFR—coronary artery disease	4.01e-06	3.16e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—JAK2—coronary artery disease	3.99e-06	3.14e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	3.94e-06	3.1e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GGT1—coronary artery disease	3.91e-06	3.08e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GOT1—coronary artery disease	3.91e-06	3.08e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—TGFB1—coronary artery disease	3.87e-06	3.05e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—NOS3—coronary artery disease	3.87e-06	3.05e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—AGT—coronary artery disease	3.81e-06	3e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—MAPK1—coronary artery disease	3.8e-06	2.99e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—APOE—coronary artery disease	3.73e-06	2.94e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GSTP1—coronary artery disease	3.73e-06	2.93e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—VCAN—coronary artery disease	3.72e-06	2.93e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PPARGC1A—coronary artery disease	3.69e-06	2.91e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—APOA1—coronary artery disease	3.69e-06	2.91e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ALDOA—coronary artery disease	3.69e-06	2.9e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—HMOX1—coronary artery disease	3.68e-06	2.89e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CXCL8—coronary artery disease	3.64e-06	2.86e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IL6—coronary artery disease	3.63e-06	2.86e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CAT—coronary artery disease	3.63e-06	2.86e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—DCN—coronary artery disease	3.58e-06	2.82e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—PIK3CA—coronary artery disease	3.57e-06	2.81e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PTGS2—coronary artery disease	3.54e-06	2.79e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—APOB—coronary artery disease	3.52e-06	2.77e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GSTP1—coronary artery disease	3.51e-06	2.77e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ALDH2—coronary artery disease	3.48e-06	2.74e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CASP3—coronary artery disease	3.48e-06	2.74e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	3.48e-06	2.74e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—HMOX1—coronary artery disease	3.46e-06	2.73e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GSTM1—coronary artery disease	3.43e-06	2.7e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CAT—coronary artery disease	3.42e-06	2.69e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—LIPC—coronary artery disease	3.39e-06	2.67e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—HBA1—coronary artery disease	3.39e-06	2.67e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	3.39e-06	2.67e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CYP2C19—coronary artery disease	3.39e-06	2.67e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCND1—coronary artery disease	3.39e-06	2.67e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—APOC3—coronary artery disease	3.37e-06	2.66e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—LPL—coronary artery disease	3.36e-06	2.65e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—LDLR—coronary artery disease	3.35e-06	2.64e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—AKT1—coronary artery disease	3.35e-06	2.64e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—APOB—coronary artery disease	3.32e-06	2.61e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GSTT1—coronary artery disease	3.31e-06	2.61e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—SLC9A1—coronary artery disease	3.31e-06	2.61e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—PIK3CA—coronary artery disease	3.29e-06	2.59e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MMP9—coronary artery disease	3.29e-06	2.59e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GPX1—coronary artery disease	3.28e-06	2.58e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GCLC—coronary artery disease	3.27e-06	2.58e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CETP—coronary artery disease	3.27e-06	2.58e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PPARG—coronary artery disease	3.25e-06	2.56e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—SDC1—coronary artery disease	3.24e-06	2.55e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GSTM1—coronary artery disease	3.23e-06	2.54e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—POMC—coronary artery disease	3.21e-06	2.53e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CD36—coronary artery disease	3.19e-06	2.51e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—LPL—coronary artery disease	3.17e-06	2.49e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL6—coronary artery disease	3.16e-06	2.49e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PPP2CA—coronary artery disease	3.15e-06	2.48e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GPX1—coronary artery disease	3.09e-06	2.43e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PSMA6—coronary artery disease	3.06e-06	2.41e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PSMB5—coronary artery disease	3.06e-06	2.41e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—MTHFR—coronary artery disease	3.03e-06	2.38e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CD36—coronary artery disease	3.01e-06	2.37e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CTGF—coronary artery disease	2.99e-06	2.35e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PPP2CA—coronary artery disease	2.97e-06	2.34e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—HMGCR—coronary artery disease	2.96e-06	2.33e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GOT2—coronary artery disease	2.96e-06	2.33e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—VEGFA—coronary artery disease	2.95e-06	2.33e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ALB—coronary artery disease	2.92e-06	2.3e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—IL6—coronary artery disease	2.92e-06	2.3e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—AKT1—coronary artery disease	2.92e-06	2.3e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—AGT—coronary artery disease	2.88e-06	2.26e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—MTHFR—coronary artery disease	2.85e-06	2.25e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—APOE—coronary artery disease	2.82e-06	2.22e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—NOS3—coronary artery disease	2.8e-06	2.2e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—APOA1—coronary artery disease	2.79e-06	2.19e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PLCB1—coronary artery disease	2.72e-06	2.14e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TGFB1—coronary artery disease	2.71e-06	2.13e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—AGT—coronary artery disease	2.71e-06	2.13e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—AKT1—coronary artery disease	2.69e-06	2.12e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MAPK1—coronary artery disease	2.66e-06	2.09e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—APOE—coronary artery disease	2.66e-06	2.09e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ABCA1—coronary artery disease	2.64e-06	2.08e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—APOA1—coronary artery disease	2.63e-06	2.07e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PTGS2—coronary artery disease	2.56e-06	2.01e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GOT1—coronary artery disease	2.56e-06	2.01e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GGT1—coronary artery disease	2.56e-06	2.01e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PPARG—coronary artery disease	2.45e-06	1.93e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—POMC—coronary artery disease	2.42e-06	1.91e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PPARG—coronary artery disease	2.31e-06	1.82e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PIK3CA—coronary artery disease	2.31e-06	1.82e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GSTP1—coronary artery disease	2.3e-06	1.81e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—POMC—coronary artery disease	2.28e-06	1.8e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	2.28e-06	1.79e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—HMOX1—coronary artery disease	2.26e-06	1.78e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CAT—coronary artery disease	2.23e-06	1.76e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ALB—coronary artery disease	2.21e-06	1.74e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PIK3CA—coronary artery disease	2.18e-06	1.71e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—APOB—coronary artery disease	2.17e-06	1.71e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—NOS3—coronary artery disease	2.11e-06	1.66e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GSTM1—coronary artery disease	2.11e-06	1.66e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ALB—coronary artery disease	2.08e-06	1.64e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—LPL—coronary artery disease	2.07e-06	1.63e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL6—coronary artery disease	2.04e-06	1.61e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GPX1—coronary artery disease	2.02e-06	1.59e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—NOS3—coronary artery disease	1.99e-06	1.57e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CD36—coronary artery disease	1.97e-06	1.55e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.94e-06	1.53e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PTGS2—coronary artery disease	1.93e-06	1.52e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—AKT1—coronary artery disease	1.88e-06	1.48e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.86e-06	1.47e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PTGS2—coronary artery disease	1.82e-06	1.43e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—AKT1—coronary artery disease	1.78e-06	1.4e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—AGT—coronary artery disease	1.77e-06	1.4e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—APOE—coronary artery disease	1.74e-06	1.37e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—APOA1—coronary artery disease	1.72e-06	1.35e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PIK3CA—coronary artery disease	1.57e-06	1.24e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PPARG—coronary artery disease	1.51e-06	1.19e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—POMC—coronary artery disease	1.49e-06	1.17e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ALB—coronary artery disease	1.36e-06	1.07e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—NOS3—coronary artery disease	1.3e-06	1.02e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—AKT1—coronary artery disease	1.29e-06	1.01e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.19e-06	9.37e-06	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PIK3CA—coronary artery disease	1.19e-06	9.35e-06	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PIK3CA—coronary artery disease	1.12e-06	8.81e-06	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—AKT1—coronary artery disease	9.7e-07	7.64e-06	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—AKT1—coronary artery disease	9.15e-07	7.2e-06	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PIK3CA—coronary artery disease	7.32e-07	5.76e-06	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—AKT1—coronary artery disease	5.98e-07	4.71e-06	CbGpPWpGaD
